OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

NCT02468700 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: Dexamethasone
OTHER: Placebo Vehicle

Sponsor

Ocular Therapeutix, Inc.

Collaborators

[object Object]